Becton Dickinson & Co (BDX)
BDX (NYSE:Health Services)
$100.40
+0.23
+0.23%
Today's Range: 99.43 - 100.56 |
BDX Avg Daily Volume: 1,009,800
| Last Update: 06/18/13 - 4:00 PM EDT |
| Volume: 478,148 |
| YTD Performance: 28.41%
|
| Open: $100.27 |
| Previous Close: $100.17 |
| 52 Week Range: $72.40 -
$102.73 |
| Oustanding Shares: 194,251,157 |
| Market Cap: 19,458,138,397 |
6-Month Chart
TheStreet Ratings Grade for BDX
| Buy |
Hold
|
Sell
|
| A+ |
A |
A- |
B+ |
B |
B- |
C+ |
C |
C- |
D+ |
D |
D- |
E+ |
E |
E- |
F |
Analysts Ratings
| Historical Rec |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
| Strong Buy |
4 |
3 |
3 |
3 |
| Moderate Buy |
1 |
1 |
1 |
1 |
| Hold |
9 |
8 |
9 |
9 |
| Moderate Sell |
2 |
2 |
2 |
2 |
| Strong Sell |
3 |
3 |
3 |
3 |
| Mean Rec. |
2.95 |
3.06 |
3.06 |
3.06 |
| Latest Dividend: |
0.50 |
| Latest Dividend Yield: |
1.98% |
| Dividend Ex-Date: |
06/05/13 |
| Price Earnings Ratio: |
17.92 |
|
| Price Earnings Comparisons: |
| BDX |
Sector Avg. |
S&P 500 |
| 17.92 |
13.30 |
17.70 |
| Price Performance History (%Change): |
| 3 Mo |
1 Yr |
3 Y |
|
9.31%
|
36.73%
|
40.77%
|
|
| GROWTH |
12 Mo |
3 Yr |
CAGR |
| Revenue |
-1.50 |
0.08 |
0.02 |
| Net Income |
-8.00 |
-0.09 |
-0.03 |
| EPS |
-0.50 |
0.11 |
0.04 |
| Earnings for BDX: |
| EBITDA |
2.07B |
| Revenue |
7.71B |
|
Average Earnings Estimates
;Qtr (09/13);FY (09/13);FY (09/14)&HEADING_LIST1=Qtr (06/12);Qtr (09/12);FY (09/12);FY (09/13)) |
|
| Average Estimate |
$1.48 |
$1.52 |
$5.75 |
$6.27 |
| Number of Analysts |
13 |
12 |
16 |
14 |
| High Estimate |
$1.53 |
$1.54 |
$5.77 |
$6.40 |
| Low Estimate |
$1.46 |
$1.50 |
$5.73 |
$6.19 |
| Prior Year |
$1.52 |
$1.42 |
$5.37 |
$5.75 |
| Growth Rate (Year over Year) |
-2.63% |
7.34% |
6.98% |
9.11% |
| Apr 26, 2013 | 12:00 PM EDT
Outperformance by safe sectors often signals trouble, but not always.
Jan 29, 2013 | 6:19 AM EST
BD Annual Shareholder Meeting - 1PM
Dec 19, 2012 | 11:41 AM EST
Portfolio Mgr. David Peltier uncovers a low-dollar healthcare stock with big growth potential.
| Nov 20, 2012 | 12:00 PM EST
This high-quality name seems ready for another sizable climb.
Aug 03, 2012 | 8:32 AM EDT
BDX was downgraded to Market Perform, Leerink Swann said. Valuation call, based on an $80 price target.
Aug 01, 2012 | 7:20 AM EDT
BDX was downgraded from Neutral to Underweight, JP Morgan said. $72 price target. Company is facing lower end-market demand.
| Jul 20, 2012 | 10:00 AM EDT
Becton Dickinson’s P/E ratio is far below the 10-year median, and its payout has become quite generous.
| Jul 18, 2012 | 9:30 AM EDT
At least three Fibonacci time cycles support a bullish stance against this recent low.
| Feb 15, 2012 | 7:00 AM EST
This surgical-products name has proven itself recession-resistant, and stands to make you money.
| Feb 07, 2012 | 8:30 AM EST
Traders awaited Greek debt-related news, testimony from Bernanke and some high-profile earnings reports.
